Pharmafile Logo
Pharmafocus logo
Advanced Search

personalised medicine

Showing 6 posts of 21 posts found.

Roche highlights R&D promise after setbacks

December 9, 2010
Research and Development MS, Roche, oncology, personalised medicine, schizophrenia

Roche has presented its pipeline to shareholders to boost confidence that it can sustain the spectacular growth of recent years. …

News

Pharma unprepared for personalised oncology

November 29, 2010
Research and Development, Sales and Marketing Cancer, ESMO, ESMO Cancer Biology for Clinicians Symposium, oncology, personalised medicine

The new era of personalised cancer care requires different thinking from pharma companies, according to experts at the ESMO symposium. …

News

Cutting-edge cancer treatments showcased at ESMO

October 18, 2010
Research and Development AstraZeneca, Boehringer, Cancer, Cancer Conference, Johnson & Johnson, Novartis, personalised medicine

The search for a ‘silver bullet’ against cancer has failed, for now, with the battle against the disease turning instead …

Feature

Roche investing $180m on US diagnostics facilities

October 18, 2010
Research and Development Diagnostics, Roche, Ventana, personalised medicine

Swiss drugmaker Roche is planning to invest $180 million and boost staff at its diagnostics subsidiary Ventana Medical Systems, as …

News

UK invests £50m in targeted research

October 13, 2010
Research and Development BIA, clinical research, genomics, personalised medicine, targeting

The government is to put more than £50 million of funding into a new initiative to produce more targeted research …

News
Wellcome Trust Sanger Institute

Study boost for personalised cancer treatments

July 23, 2010
Research and Development Cancer, genome, genomics, personalised medicine

A five-year study by scientists in the UK and US of the way genomes and cancer medicines interact has yielded …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025